Immunotherapy of relapsed B-cell lymphoma with an anti-CD20 antibody (IDEC-C2B8)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy of relapsed B-cell lymphoma with an anti-CD20 antibody (IDEC-C2B8)

Published:1996-02 Issue:1 Volume:2 Page:65-66
ISSN:1380-2933
Container-title:Immunotechnology
language:en
Short-container-title:Immunotechnology

Author:

Grillo-López A.J.

Publisher

Elsevier BV

Subject

Immunology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Demystifying Cancer Immunotherapy for Lay Audiences;Frontiers in Immunology;2019-10-18

2. Genetic and Epigenetic Modulation of CD20 Expression in B-Cell Malignancies: Molecular Mechanisms and Significance to Rituximab Resistance;Journal of Clinical and Experimental Hematopathology;2016

3. A case of malignant lymphoma arising in the margin of the tongue;Japanese Journal of Oral and Maxillofacial Surgery;2011

4. B-Cell Non-Hodgkin Lymphoma: PET/CT Evaluation after90Y–Ibritumomab Tiuxetan Radioimmunotherapy—Initial Experience1;Radiology;2008-03

5. Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma;Journal of Clinical Oncology;2002-05-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP